Markets:

Overview

News

Currencies

International

Treasuries

Aerovate Therapeutics, Inc. - Common Stock (NQ:AVTE)

2.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aerovate Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

The trading volume of these stocks is deviating from the norm in today's session. ↗

April 28, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News ↗

April 15, 2025

Via Stocktwits

Aerovate Therapeutics Stock Bucks Broader Market Sell-Off Over Dividend Announcement: Stock Rises But Retail’s Unmoved ↗

April 07, 2025

The company said that the official declaration of the cash dividend will be subject to the approval of Aerovate board of directors and is expected to be announced later this month.

Via Stocktwits

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

Recap: Aerovate Therapeutics Q4 Earnings ↗

March 25, 2024

Via Benzinga

Recap: Aerovate Therapeutics Q3 Earnings ↗

November 13, 2023

Via Benzinga

Recap: Aerovate Therapeutics Q1 Earnings ↗

May 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 01, 2024

Via Benzinga

AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q2 2024 ↗

August 12, 2024

AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

The 3 Hottest Stock Downgrades From Last Week ↗

June 27, 2024

Explore the experts' latest surprising stock downgrades amid significant market shifts and analyst adjustments.

Via InvestorPlace

Nasdaq Surges Over 200 Points; Aaron's Shares Jump ↗

June 17, 2024

Via Benzinga

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 17, 2024

Via Benzinga

Crude Oil Rises 1%; Mustang Bio Shares Spike Higher ↗

June 17, 2024

Via Benzinga

Why 90% Of Aerovate Therapeutics' Value Just Went Up In Smoke ↗

June 17, 2024

The company was working on a treatment for pulmonary arterial hypertension, a form of high blood pressure in the lungs.

Via Investor's Business Daily

Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday? ↗

June 17, 2024

Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hypertension. Despite being well tolerated, AV-101 failed to meet primary...

Via Benzinga

US Stocks Mixed; Dow Tumbles Over 100 Points ↗

June 17, 2024

Via Benzinga

Topics Stocks

AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q1 2024 ↗

May 13, 2024

AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday ↗

April 05, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Friday. Shares of Ermenegildo Zegna N.V. (NYSE: ZGN) fell sharply during Friday’s session as the company reported FY23...

Via Benzinga

Topics Stocks

AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q4 2023 ↗

March 25, 2024

AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More ↗

February 21, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Ambrx Biopharma, PaxMedica And 3 More Short Squeeze Stocks That Could Soar This Week ↗

January 09, 2023

Potential short squeeze plays gained steam in 2021 and have continued to attract attention, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the...

Via Benzinga

Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week ↗

December 27, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common...

Via Benzinga

Singing Machine, SurgePays And 3 More Short Squeeze Stocks That Could Soar This Week ↗

December 19, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common...

Via Benzinga

JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday ↗

December 13, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Dow Jumps 600 Points; US Inflation Rate Slows In November ↗

December 13, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 600 points on Tuesday

Via Benzinga

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

December 12, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.